Estado actual del trasplante pulmonar

Translated title of the contribution: Lung transplantation. State of the art

Lisardo García-Covarrubias, Tomas Salerno, Anthony L. Panos, Si M. Pham

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Lung transplantation is currently considered an established treatment for some advanced lung diseases. The beginning of experimental lung transplantation dates back to the 1940's when the Soviet Vladimir P. Demikhov performed the first lung transplants in animals. Two decades later, James Hardy performed the first lung transplant in humans. Unfortunately, the beginning of clinical lung transplantation was hampered by technical complications and the excessive toxicity of immunosuppressive drugs. Improvement in the surgical technique along with the development of more effective and less toxic immunosuppressive drugs has led to a better outcome in lunt transplant recipients. Donor selection and management before organ procurement play a key role in the receptor's outcome. Due to the shortage of donors, some institutions are using more liberal selection criteria, reporting satisfactory outcomes. The approach of the lung and heart-lung transplant patient is multidisciplinary and includes the cardiothoracic transplant surgeon, pulmonologist, anesthesiologist, and intensivist, among others. Herein, we review some relevant historical aspects and recent advances in the management of lung transplant recipients, including indications and contraindications, evaluation of donors and recipients, surgical techniques and peripost-operative care.

Original languageSpanish
Pages (from-to)323-332
Number of pages10
JournalGaceta Medica de Mexico
Volume143
Issue number4
StatePublished - Dec 1 2007

Fingerprint

Lung Transplantation
Lung
Transplants
Immunosuppressive Agents
Tissue Donors
Donor Selection
Tissue and Organ Procurement
Poisons
Drug-Related Side Effects and Adverse Reactions
Patient Selection
Lung Diseases
History
Pharmaceutical Preparations

Keywords

  • Advances
  • Indications
  • Lung
  • Management
  • Transplantation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

García-Covarrubias, L., Salerno, T., Panos, A. L., & Pham, S. M. (2007). Estado actual del trasplante pulmonar. Gaceta Medica de Mexico, 143(4), 323-332.

Estado actual del trasplante pulmonar. / García-Covarrubias, Lisardo; Salerno, Tomas; Panos, Anthony L.; Pham, Si M.

In: Gaceta Medica de Mexico, Vol. 143, No. 4, 01.12.2007, p. 323-332.

Research output: Contribution to journalArticle

García-Covarrubias, L, Salerno, T, Panos, AL & Pham, SM 2007, 'Estado actual del trasplante pulmonar', Gaceta Medica de Mexico, vol. 143, no. 4, pp. 323-332.
García-Covarrubias L, Salerno T, Panos AL, Pham SM. Estado actual del trasplante pulmonar. Gaceta Medica de Mexico. 2007 Dec 1;143(4):323-332.
García-Covarrubias, Lisardo ; Salerno, Tomas ; Panos, Anthony L. ; Pham, Si M. / Estado actual del trasplante pulmonar. In: Gaceta Medica de Mexico. 2007 ; Vol. 143, No. 4. pp. 323-332.
@article{e131fe2fa04045a49ae6f73d07f24cbb,
title = "Estado actual del trasplante pulmonar",
abstract = "Lung transplantation is currently considered an established treatment for some advanced lung diseases. The beginning of experimental lung transplantation dates back to the 1940's when the Soviet Vladimir P. Demikhov performed the first lung transplants in animals. Two decades later, James Hardy performed the first lung transplant in humans. Unfortunately, the beginning of clinical lung transplantation was hampered by technical complications and the excessive toxicity of immunosuppressive drugs. Improvement in the surgical technique along with the development of more effective and less toxic immunosuppressive drugs has led to a better outcome in lunt transplant recipients. Donor selection and management before organ procurement play a key role in the receptor's outcome. Due to the shortage of donors, some institutions are using more liberal selection criteria, reporting satisfactory outcomes. The approach of the lung and heart-lung transplant patient is multidisciplinary and includes the cardiothoracic transplant surgeon, pulmonologist, anesthesiologist, and intensivist, among others. Herein, we review some relevant historical aspects and recent advances in the management of lung transplant recipients, including indications and contraindications, evaluation of donors and recipients, surgical techniques and peripost-operative care.",
keywords = "Advances, Indications, Lung, Management, Transplantation",
author = "Lisardo Garc{\'i}a-Covarrubias and Tomas Salerno and Panos, {Anthony L.} and Pham, {Si M.}",
year = "2007",
month = "12",
day = "1",
language = "Spanish",
volume = "143",
pages = "323--332",
journal = "Gaceta Medica de Mexico",
issn = "0016-3813",
publisher = "Academia Nacional de Medicina",
number = "4",

}

TY - JOUR

T1 - Estado actual del trasplante pulmonar

AU - García-Covarrubias, Lisardo

AU - Salerno, Tomas

AU - Panos, Anthony L.

AU - Pham, Si M.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Lung transplantation is currently considered an established treatment for some advanced lung diseases. The beginning of experimental lung transplantation dates back to the 1940's when the Soviet Vladimir P. Demikhov performed the first lung transplants in animals. Two decades later, James Hardy performed the first lung transplant in humans. Unfortunately, the beginning of clinical lung transplantation was hampered by technical complications and the excessive toxicity of immunosuppressive drugs. Improvement in the surgical technique along with the development of more effective and less toxic immunosuppressive drugs has led to a better outcome in lunt transplant recipients. Donor selection and management before organ procurement play a key role in the receptor's outcome. Due to the shortage of donors, some institutions are using more liberal selection criteria, reporting satisfactory outcomes. The approach of the lung and heart-lung transplant patient is multidisciplinary and includes the cardiothoracic transplant surgeon, pulmonologist, anesthesiologist, and intensivist, among others. Herein, we review some relevant historical aspects and recent advances in the management of lung transplant recipients, including indications and contraindications, evaluation of donors and recipients, surgical techniques and peripost-operative care.

AB - Lung transplantation is currently considered an established treatment for some advanced lung diseases. The beginning of experimental lung transplantation dates back to the 1940's when the Soviet Vladimir P. Demikhov performed the first lung transplants in animals. Two decades later, James Hardy performed the first lung transplant in humans. Unfortunately, the beginning of clinical lung transplantation was hampered by technical complications and the excessive toxicity of immunosuppressive drugs. Improvement in the surgical technique along with the development of more effective and less toxic immunosuppressive drugs has led to a better outcome in lunt transplant recipients. Donor selection and management before organ procurement play a key role in the receptor's outcome. Due to the shortage of donors, some institutions are using more liberal selection criteria, reporting satisfactory outcomes. The approach of the lung and heart-lung transplant patient is multidisciplinary and includes the cardiothoracic transplant surgeon, pulmonologist, anesthesiologist, and intensivist, among others. Herein, we review some relevant historical aspects and recent advances in the management of lung transplant recipients, including indications and contraindications, evaluation of donors and recipients, surgical techniques and peripost-operative care.

KW - Advances

KW - Indications

KW - Lung

KW - Management

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=44949248935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44949248935&partnerID=8YFLogxK

M3 - Article

C2 - 17969841

AN - SCOPUS:44949248935

VL - 143

SP - 323

EP - 332

JO - Gaceta Medica de Mexico

JF - Gaceta Medica de Mexico

SN - 0016-3813

IS - 4

ER -